151 related articles for article (PubMed ID: 9718222)
1. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
2. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
5. Perineal exposure to talc and ovarian cancer risk.
Harlow BL; Cramer DW; Bell DA; Welch WR
Obstet Gynecol; 1992 Jul; 80(1):19-26. PubMed ID: 1603491
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of analgesic use and ovarian cancer.
Rosenberg L; Palmer JR; Rao RS; Coogan PF; Strom BL; Zauber AG; Stolley PD; Shapiro S
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):933-7. PubMed ID: 11008911
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia, psychotropic medication, and cataract.
McCarty CA; Wood CA; Fu CL; Livingston PM; Mackersey S; Stanislavsky Y; Taylor HR
Ophthalmology; 1999 Apr; 106(4):683-7. PubMed ID: 10201587
[TBL] [Abstract][Full Text] [Related]
11. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant medication use [corrected] and risk of ovarian cancer.
Moorman PG; Berchuck A; Calingaert B; Halabi S; Schildkraut JM
Obstet Gynecol; 2005 Apr; 105(4):725-30. PubMed ID: 15802397
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
15. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of galactose consumption and metabolism in relation to ovarian cancer.
Cramer DW; Greenberg ER; Titus-Ernstoff L; Liberman RF; Welch WR; Li E; Ng WG
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):95-101. PubMed ID: 10667469
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
18. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer risk and use of phenolphthalein-containing laxatives.
Cooper GS; Longnecker MP; Peters RK
Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):35-9. PubMed ID: 14971121
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement therapy and risk of epithelial ovarian cancer.
Risch HA
Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
